Commensal epitopes drive differentiation of colonic T<sub>regs</sub>.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32494613.
- Also identified by DOI 10.1126/sciadv.aaz3186 and PMC identifier 7164940.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The gut microbiome is the largest source of intrinsic non-self-antigens that are continuously sensed by the immune system but typically do not elicit lymphocyte responses. CD4<sup>+</sup> T cells are critical to sustain uninterrupted tolerance to microbial antigens and to prevent intestinal inflammation. However, clinical interventions targeting commensal bacteria-specific CD4<sup>+</sup> T cells are rare, because only a very limited number of commensal-derived epitopes have been identified. Here, we used a new approach to study epitopes and identify T cell receptors expressed by CD4<sup>+</sup>Foxp3<sup>+</sup> (T<sub>reg</sub>) cells specific for commensal-derived antigens. Using this approach, we found that antigens from <i>Akkermansia muciniphila</i> reprogram naïve CD4<sup>+</sup> T cells to the T<sub>reg</sub> lineage, expand preexisting microbe specific T<sub>regs</sub>, and limit wasting disease in the CD4<sup>+</sup> T cell transfer model of colitis. These data suggest that the administration of specific commensal epitopes may help to widen the repertoire of specific T<sub>regs</sub> that control intestinal inflammation.